Drugmaker sues competitor for alleged sham litigation

Biopharmaceutical company Dicerna Pharmaceuticals has sued Alnylam Pharmaceuticals for allegedly using sham litigation and public announcements against Dicerna to illegally obtain market dominance.

Get unlimited access to all Global Competition Review content